| |
|
|
|
Plus Therapeutics Inc  
|
|
1.88 -0.01 (-0.01%) |
09-28 16:00 |
|
Open: |
1.9 |
Pre close: |
1.89 |
Target:
|
2.44
|
|
High: |
1.925 |
Low: |
1.85 |
Resistance:
|
2.09
2.30
|
|
Volume: |
412,854 |
Market Cap: |
29M |
Support:
|
1.75
1.46
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.94
 |
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
1.93  |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
2.21 |
Stochastic Oscillator |
%K(14,3):
|
61.10 |
|
MA(250): |
2.36 |
%D(3): |
57.56 |
|
Average Volume(K) |
3-Month: |
11591985
|
52-Week |
High:
|
5.42 |
|
10-Days: |
54478 |
Low: |
1.75 |
|
RSI |
RSI(14):
|
44.26 |
Change(%): |
-26.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-30.616 |
Return on Equity (ttm) |
-205.8 |
Shares Out. (M) |
21.11 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-28.1 |
Shares Float (M) |
21.06 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.33 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
2.25 |
|
Forward EPS |
-8.270 |
Gross Profit (p.s.) |
-0.114 |
Shares Short (K) |
972 |
|
Book Value (p.s.) |
0.060 |
EBITDA (p.s.) |
-0.402 |
P/E |
-0.06 |
|
Sales Per Share |
0.009 |
Qtrly Earnings Growth |
0.00 |
P/BV |
31.33 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-9.94 |
P/S |
214.52 |
|
Operating Margin |
-4778.92 |
Levered Free Cash Flow
(M) |
-6.62 |
P/CF |
-3.99 |
|
|
|
|
|
|
